HBA-NRS H.C.R. 8 77(R)    BILL ANALYSIS


Office of House Bill AnalysisH.C.R. 8
By: Marchant
Public Health
3/28/2001
Introduced



BACKGROUND AND PURPOSE 

Muscular dystrophy is a disease that encompasses a large group of
hereditary muscle-destroying disorders, with Duchenne muscular dystrophy
being the most common disorder and the most fatal childhood genetic
disease. Continuing research on muscular dystrophy is important to
understanding the disease, treating it, and working towards its prevention
and cure. Congressional funding for research by the National Institutes of
Health on Duchenne and Becker muscular dystrophy does not reflect the
severity of this disease, the importance of finding a cure, or the
potential benefits that research in this area could have on other similar
disorders. House Concurrent Resolution 8 urges the United States Congress
to increase funding for the research of Duchenne and Becker muscular
dystrophy. 

RULEMAKING AUTHORITY

It is the opinion of the Office of House Bill Analysis that this bill does
not expressly delegate any additional rulemaking authority to a state
officer, department, agency, or institution. 

ANALYSIS

House Concurrent Resolution 8 urges the Congress of the United States to
increase funding for research by the National Institutes of Health for the
treatment and cure of Duchenne and Becker muscular dystrophy.